---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-122284"
form_type: "8-K"
ticker: "CERT"
cik: "0001827090"
company_name: "Certara, Inc."
filed_at: "2021-10-04T23:59:59+00:00"
generated_at: "2026-06-28T23:32:11.662164+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Certara completes $310M acquisition of Pinnacle 21, a clinical data compliance SaaS provider

## Summary
- Enterprise value $310M; ~$250M cash + 2,239,717 restricted shares to equityholders.
- Pinnacle 21 software validates CDISC compliance required by FDA and PMDA.
- Transaction expected to be accretive to Certara's revenue, growth, and adjusted EBITDA.
- Pinnacle 21 used by FDA, PMDA, and 22 of top 25 biopharma R&D spenders.

## SEC filing metadata
- accession: 0001104659-21-122284
- form_type: 8-K
- ticker: CERT
- cik: 0001827090
- company_name: Certara, Inc.
- filed_at: 2021-10-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1827090/000110465921122284/0001104659-21-122284-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1827090/000110465921122284/tm2129045d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-122284
- JSON: https://secwatch.observer/filing/0001104659-21-122284.json
- Plain text: https://secwatch.observer/filing/0001104659-21-122284.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.